The major limitation of the study was that oxidative stress was not measured in colonic biopsies and compared with oxidative stress in erythrocytes
Initially developed for diabetes, it gained FDA approval in 2021 for chronic weight loss, thanks to successful clinical trials like the STEP program
Recent FDA warnings have targeted specific compounders shipping unsterile or mislabeled products, not the compounding model itself
Energy stays high, so patients can keep walking, lifting, and doing what they love
Their 9.4 Finnrick rating is well-earned and reflects their commitment to the research community
The structural basis for this triple activity was elucidated through 2024 cryo-EM studies, which showed that retatrutides 26-amino acid backbone adopts distinct helical conformations at each receptor interface, explaining how balanced agonism across all three receptors is achievable without sacrificing binding affinity at any single target [9]
